Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
Slower Digestion: It slows down how quickly food leaves your stomach
In rare instances, allergic or anaphylactoid reactions have been reported with folic acid use
All medications may have potential risks and side effects
Lipo B12 Injections New Braunfels Lipo B12 injections combine lipotropic compounds with vitamin B12 to help with both fat metabolism and energy levels
Strokes are mostly caused by arterial occlusion, which in turn leads to cerebral ischemia, brain damage, and then nerve damage and disability